Cellectis (CLLS) Revenue (2015 - 2026)

Cellectis' Revenue history runs 12 years deep, the most recent figure standing at $5.8 million for Q1 2026.

• On a quarterly basis, Revenue fell 45.78% year-over-year to $5.8 million in Q1 2026; TTM through Mar 2026 was $70.4 million, a 47.78% increase from a year earlier, with the FY2025 full-year figure at $72.9 million, up 75.76% from the prior year.
• Revenue retreated to $5.8 million in Q1 2026 per CLLS's latest filing, from $12.7 million in the prior quarter.
• Across five years, Revenue topped out at $35.2 million in Q3 2025 and bottomed at $139000.0 in Q1 2023.
• The 5-year median for Revenue is $5.8 million (2026), against an average of $8.4 million.
• Across the five-year window, Revenue sank 98.23% in 2023 and jumped 10351.61% in 2024, its largest moves.
• Year by year, Revenue stood at $16.0 million in 2022, then sank by 98.23% to $283000.0 in 2023, then soared by 4393.29% to $12.7 million in 2024, then changed by 0.0% to $12.7 million in 2025, then plunged by 54.57% to $5.8 million in 2026.
• Per Business Quant, the three latest CLLS Revenue figures stand at $5.8 million (Q1 2026), $12.7 million (Q4 2025), and $35.2 million (Q3 2025).